Smoking and Parkinson's disease: Systematic review of prospective studies
Identifieur interne : 002139 ( PascalFrancis/Corpus ); précédent : 002138; suivant : 002140Smoking and Parkinson's disease: Systematic review of prospective studies
Auteurs : MOHAMED FAROUK ALLAM ; Michael J. Campbell ; Albert Hofman ; Amparo Serrano Del Castillo ; Rafael Fernandez-Crehuet NavajasSource :
- Movement disorders [ 0885-3185 ] ; 2004.
Descripteurs français
- Pascal (Inist)
English descriptors
Abstract
We estimated the pooled risk of tobacco smoking for Parkinson's disease (PD). Inclusion criteria included systematic searches of MedLine, PsycLIT, Embase, Current Contents, previously published reviews, examination of cited reference sources, and personal contact and discussion with several investigators expert in the field. Published prospective studies on PD and cigarette smoking. When two or more studies were based on an identical study, the study that principally investigated the relationship or the study that was published last was used. Seven prospective studies were carried out between 1959 and 1997, of which six reported risk estimates. Four cohorts were based on standardised mortality rates, which were exclusively of male. Only one study included risk estimates for both males and females separately. The risk of ever smoker was 0.51 (95% confidence interval, 0.43 to 0.61). There was an obvious protective effect of current smoking in the pooled estimate (relative risk, 0.35; 95% Cl, 0.26-0.47). Former smokers had lower risk compared with never smokers (relative risk, 0.66; 95% CI, 0.49-0.88). Although our pooled estimates show that smoking is inversely associated with the risk of PD, the four prospective studies that were based on follow-up of mortality of smokers had many limitations. Further studies evaluating the association between smoking and PD in women are strongly needed.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
| pA |
|
|---|
Format Inist (serveur)
| NO : | PASCAL 04-0415337 INIST |
|---|---|
| ET : | Smoking and Parkinson's disease: Systematic review of prospective studies |
| AU : | MOHAMED FAROUK ALLAM; CAMPBELL (Michael J.); HOFMAN (Albert); DEL CASTILLO (Amparo Serrano); NAVAJAS (Rafael Fernandez-Crehuet) |
| AF : | Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba/Cordoba/Espagne (1 aut., 4 aut., 5 aut.); Institute of General Practice and Primary Care, University of Sheffield/Sheffield/Royaume-Uni (2 aut.); Department of Epidemiology and Biostatistics, Erasmus Medical Center Rotterdam/Rotterdam/Pays-Bas (3 aut.) |
| DT : | Publication en série; Niveau analytique |
| SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2004; Vol. 19; No. 6; Pp. 614-621; Bibl. 62 ref. |
| LA : | Anglais |
| EA : | We estimated the pooled risk of tobacco smoking for Parkinson's disease (PD). Inclusion criteria included systematic searches of MedLine, PsycLIT, Embase, Current Contents, previously published reviews, examination of cited reference sources, and personal contact and discussion with several investigators expert in the field. Published prospective studies on PD and cigarette smoking. When two or more studies were based on an identical study, the study that principally investigated the relationship or the study that was published last was used. Seven prospective studies were carried out between 1959 and 1997, of which six reported risk estimates. Four cohorts were based on standardised mortality rates, which were exclusively of male. Only one study included risk estimates for both males and females separately. The risk of ever smoker was 0.51 (95% confidence interval, 0.43 to 0.61). There was an obvious protective effect of current smoking in the pooled estimate (relative risk, 0.35; 95% Cl, 0.26-0.47). Former smokers had lower risk compared with never smokers (relative risk, 0.66; 95% CI, 0.49-0.88). Although our pooled estimates show that smoking is inversely associated with the risk of PD, the four prospective studies that were based on follow-up of mortality of smokers had many limitations. Further studies evaluating the association between smoking and PD in women are strongly needed. |
| CC : | 002B17 |
| FD : | Tabagisme; Parkinson maladie; Système nerveux pathologie |
| FG : | Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie |
| ED : | Tobacco smoking; Parkinson disease; Nervous system diseases |
| EG : | Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease |
| SD : | Tabaquismo; Parkinson enfermedad; Sistema nervioso patología |
| LO : | INIST-20953.354000113781310010 |
| ID : | 04-0415337 |
Links to Exploration step
Pascal:04-0415337Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Smoking and Parkinson's disease: Systematic review of prospective studies</title><author><name sortKey="Mohamed Farouk Allam" sort="Mohamed Farouk Allam" uniqKey="Mohamed Farouk Allam" last="Mohamed Farouk Allam">MOHAMED FAROUK ALLAM</name><affiliation><inist:fA14 i1="01"><s1>Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba</s1><s2>Cordoba</s2><s3>ESP</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Campbell, Michael J" sort="Campbell, Michael J" uniqKey="Campbell M" first="Michael J." last="Campbell">Michael J. Campbell</name><affiliation><inist:fA14 i1="02"><s1>Institute of General Practice and Primary Care, University of Sheffield</s1><s2>Sheffield</s2><s3>GBR</s3><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Hofman, Albert" sort="Hofman, Albert" uniqKey="Hofman A" first="Albert" last="Hofman">Albert Hofman</name><affiliation><inist:fA14 i1="03"><s1>Department of Epidemiology and Biostatistics, Erasmus Medical Center Rotterdam</s1><s2>Rotterdam</s2><s3>NLD</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Del Castillo, Amparo Serrano" sort="Del Castillo, Amparo Serrano" uniqKey="Del Castillo A" first="Amparo Serrano" last="Del Castillo">Amparo Serrano Del Castillo</name><affiliation><inist:fA14 i1="01"><s1>Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba</s1><s2>Cordoba</s2><s3>ESP</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Navajas, Rafael Fernandez Crehuet" sort="Navajas, Rafael Fernandez Crehuet" uniqKey="Navajas R" first="Rafael Fernandez-Crehuet" last="Navajas">Rafael Fernandez-Crehuet Navajas</name><affiliation><inist:fA14 i1="01"><s1>Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba</s1><s2>Cordoba</s2><s3>ESP</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">04-0415337</idno><date when="2004">2004</date><idno type="stanalyst">PASCAL 04-0415337 INIST</idno><idno type="RBID">Pascal:04-0415337</idno><idno type="wicri:Area/PascalFrancis/Corpus">002139</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Smoking and Parkinson's disease: Systematic review of prospective studies</title><author><name sortKey="Mohamed Farouk Allam" sort="Mohamed Farouk Allam" uniqKey="Mohamed Farouk Allam" last="Mohamed Farouk Allam">MOHAMED FAROUK ALLAM</name><affiliation><inist:fA14 i1="01"><s1>Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba</s1><s2>Cordoba</s2><s3>ESP</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Campbell, Michael J" sort="Campbell, Michael J" uniqKey="Campbell M" first="Michael J." last="Campbell">Michael J. Campbell</name><affiliation><inist:fA14 i1="02"><s1>Institute of General Practice and Primary Care, University of Sheffield</s1><s2>Sheffield</s2><s3>GBR</s3><sZ>2 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Hofman, Albert" sort="Hofman, Albert" uniqKey="Hofman A" first="Albert" last="Hofman">Albert Hofman</name><affiliation><inist:fA14 i1="03"><s1>Department of Epidemiology and Biostatistics, Erasmus Medical Center Rotterdam</s1><s2>Rotterdam</s2><s3>NLD</s3><sZ>3 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Del Castillo, Amparo Serrano" sort="Del Castillo, Amparo Serrano" uniqKey="Del Castillo A" first="Amparo Serrano" last="Del Castillo">Amparo Serrano Del Castillo</name><affiliation><inist:fA14 i1="01"><s1>Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba</s1><s2>Cordoba</s2><s3>ESP</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author><author><name sortKey="Navajas, Rafael Fernandez Crehuet" sort="Navajas, Rafael Fernandez Crehuet" uniqKey="Navajas R" first="Rafael Fernandez-Crehuet" last="Navajas">Rafael Fernandez-Crehuet Navajas</name><affiliation><inist:fA14 i1="01"><s1>Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba</s1><s2>Cordoba</s2><s3>ESP</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14></affiliation></author></analytic><series><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno><imprint><date when="2004">2004</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Movement disorders</title><title level="j" type="abbreviated">Mov. disord.</title><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Nervous system diseases</term><term>Parkinson disease</term><term>Tobacco smoking</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Tabagisme</term><term>Parkinson maladie</term><term>Système nerveux pathologie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We estimated the pooled risk of tobacco smoking for Parkinson's disease (PD). Inclusion criteria included systematic searches of MedLine, PsycLIT, Embase, Current Contents, previously published reviews, examination of cited reference sources, and personal contact and discussion with several investigators expert in the field. Published prospective studies on PD and cigarette smoking. When two or more studies were based on an identical study, the study that principally investigated the relationship or the study that was published last was used. Seven prospective studies were carried out between 1959 and 1997, of which six reported risk estimates. Four cohorts were based on standardised mortality rates, which were exclusively of male. Only one study included risk estimates for both males and females separately. The risk of ever smoker was 0.51 (95% confidence interval, 0.43 to 0.61). There was an obvious protective effect of current smoking in the pooled estimate (relative risk, 0.35; 95% Cl, 0.26-0.47). Former smokers had lower risk compared with never smokers (relative risk, 0.66; 95% CI, 0.49-0.88). Although our pooled estimates show that smoking is inversely associated with the risk of PD, the four prospective studies that were based on follow-up of mortality of smokers had many limitations. Further studies evaluating the association between smoking and PD in women are strongly needed.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0></fA01><fA03 i2="1"><s0>Mov. disord.</s0></fA03><fA05><s2>19</s2></fA05><fA06><s2>6</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Smoking and Parkinson's disease: Systematic review of prospective studies</s1></fA08><fA11 i1="01" i2="1"><s1>MOHAMED FAROUK ALLAM</s1></fA11><fA11 i1="02" i2="1"><s1>CAMPBELL (Michael J.)</s1></fA11><fA11 i1="03" i2="1"><s1>HOFMAN (Albert)</s1></fA11><fA11 i1="04" i2="1"><s1>DEL CASTILLO (Amparo Serrano)</s1></fA11><fA11 i1="05" i2="1"><s1>NAVAJAS (Rafael Fernandez-Crehuet)</s1></fA11><fA14 i1="01"><s1>Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba</s1><s2>Cordoba</s2><s3>ESP</s3><sZ>1 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ></fA14><fA14 i1="02"><s1>Institute of General Practice and Primary Care, University of Sheffield</s1><s2>Sheffield</s2><s3>GBR</s3><sZ>2 aut.</sZ></fA14><fA14 i1="03"><s1>Department of Epidemiology and Biostatistics, Erasmus Medical Center Rotterdam</s1><s2>Rotterdam</s2><s3>NLD</s3><sZ>3 aut.</sZ></fA14><fA20><s1>614-621</s1></fA20><fA21><s1>2004</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>20953</s2><s5>354000113781310010</s5></fA43><fA44><s0>0000</s0><s1>© 2004 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>62 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>04-0415337</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>Movement disorders</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>We estimated the pooled risk of tobacco smoking for Parkinson's disease (PD). Inclusion criteria included systematic searches of MedLine, PsycLIT, Embase, Current Contents, previously published reviews, examination of cited reference sources, and personal contact and discussion with several investigators expert in the field. Published prospective studies on PD and cigarette smoking. When two or more studies were based on an identical study, the study that principally investigated the relationship or the study that was published last was used. Seven prospective studies were carried out between 1959 and 1997, of which six reported risk estimates. Four cohorts were based on standardised mortality rates, which were exclusively of male. Only one study included risk estimates for both males and females separately. The risk of ever smoker was 0.51 (95% confidence interval, 0.43 to 0.61). There was an obvious protective effect of current smoking in the pooled estimate (relative risk, 0.35; 95% Cl, 0.26-0.47). Former smokers had lower risk compared with never smokers (relative risk, 0.66; 95% CI, 0.49-0.88). Although our pooled estimates show that smoking is inversely associated with the risk of PD, the four prospective studies that were based on follow-up of mortality of smokers had many limitations. Further studies evaluating the association between smoking and PD in women are strongly needed.</s0></fC01><fC02 i1="01" i2="X"><s0>002B17</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Tabagisme</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Tobacco smoking</s0><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Tabaquismo</s0><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Parkinson maladie</s0><s5>04</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Parkinson disease</s0><s5>04</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Parkinson enfermedad</s0><s5>04</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Système nerveux pathologie</s0><s5>07</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0><s5>07</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0><s5>07</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0><s5>37</s5></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0><s5>37</s5></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0><s5>38</s5></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0><s5>38</s5></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0><s5>39</s5></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0><s5>39</s5></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0><s5>40</s5></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0><s5>40</s5></fC07><fN21><s1>236</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard><server><NO>PASCAL 04-0415337 INIST</NO><ET>Smoking and Parkinson's disease: Systematic review of prospective studies</ET><AU>MOHAMED FAROUK ALLAM; CAMPBELL (Michael J.); HOFMAN (Albert); DEL CASTILLO (Amparo Serrano); NAVAJAS (Rafael Fernandez-Crehuet)</AU><AF>Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba/Cordoba/Espagne (1 aut., 4 aut., 5 aut.); Institute of General Practice and Primary Care, University of Sheffield/Sheffield/Royaume-Uni (2 aut.); Department of Epidemiology and Biostatistics, Erasmus Medical Center Rotterdam/Rotterdam/Pays-Bas (3 aut.)</AF><DT>Publication en série; Niveau analytique</DT><SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2004; Vol. 19; No. 6; Pp. 614-621; Bibl. 62 ref.</SO><LA>Anglais</LA><EA>We estimated the pooled risk of tobacco smoking for Parkinson's disease (PD). Inclusion criteria included systematic searches of MedLine, PsycLIT, Embase, Current Contents, previously published reviews, examination of cited reference sources, and personal contact and discussion with several investigators expert in the field. Published prospective studies on PD and cigarette smoking. When two or more studies were based on an identical study, the study that principally investigated the relationship or the study that was published last was used. Seven prospective studies were carried out between 1959 and 1997, of which six reported risk estimates. Four cohorts were based on standardised mortality rates, which were exclusively of male. Only one study included risk estimates for both males and females separately. The risk of ever smoker was 0.51 (95% confidence interval, 0.43 to 0.61). There was an obvious protective effect of current smoking in the pooled estimate (relative risk, 0.35; 95% Cl, 0.26-0.47). Former smokers had lower risk compared with never smokers (relative risk, 0.66; 95% CI, 0.49-0.88). Although our pooled estimates show that smoking is inversely associated with the risk of PD, the four prospective studies that were based on follow-up of mortality of smokers had many limitations. Further studies evaluating the association between smoking and PD in women are strongly needed.</EA><CC>002B17</CC><FD>Tabagisme; Parkinson maladie; Système nerveux pathologie</FD><FG>Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie</FG><ED>Tobacco smoking; Parkinson disease; Nervous system diseases</ED><EG>Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease</EG><SD>Tabaquismo; Parkinson enfermedad; Sistema nervioso patología</SD><LO>INIST-20953.354000113781310010</LO><ID>04-0415337</ID></server></inist></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002139 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002139 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:04-0415337
|texte= Smoking and Parkinson's disease: Systematic review of prospective studies
}}
| This area was generated with Dilib version V0.6.23. |  |